This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
A

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in Stage III BRAF-Mutated Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Axel Hauschild
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Axel Hauschild
472 views
June 11, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: Skin Videos

05:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical…

Feat. L. Burton
35:23
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

Feat. S. Patel
24:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and A…

Feat. Z. Eroglu
View All

Related Content

AUTOPLAY
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
25:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Insights in Melanoma"

Feat. O. Hamid
18:28
Vanderbilt University Medical Center (VUMC)

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Feat. D. Johnson
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
08:41
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in …

Feat. C. Blank
55:10
University of Colorado Cancer Center

History of Cancer and Its Treatment: What Will It Take to Cure?

Feat. C. Lieu
11:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We B…

Feat. P. Corrie
17:07
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Melanoma Brain Metastases: Successes, Failures, and Future Opportuni…

Feat. M. Postow
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
15:18
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Me…

Feat. A. Betof Warner
20:16
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in S…

Feat. H. Tawbi
10:37
Vanderbilt University Medical Center (VUMC)

Understanding Treatment Sequencing in Metastatic Melanoma: IO vs. Ta…

Feat. D. Johnson
05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
14:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immuno…

Feat. H. Kluger
21:29
14th Annual LA Melanoma Symposium

Clinical Trial Options for Melanoma: New Data and Future Therapies

Feat. R. Sullivan
28:02
14th Annual LA Melanoma Symposium

Uveal, Mucosal, and Acral Melanoma: Current Care and Future Directio…

Feat. I. Mehmi
21:27
14th Annual LA Melanoma Symposium

Cellular Therapy in Melanoma: TIL Tomorrow and Further

Feat. M. Faries
20:55
2023 West Oncology Conference

2023 West Oncology Conference: Melanoma Updates

Feat. M. Mooradian
37:16
University of Miami Sylvester Comprehensive Cancer Center

The TAPUR Study: Evaluating Targeted Therapies Based on Genetic Alte…

Feat. R. Schilsky